1. Home
  2. ANIX vs PFX Comparison

ANIX vs PFX Comparison

Compare ANIX & PFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANIX
  • PFX
  • Stock Information
  • Founded
  • ANIX 1982
  • PFX 2010
  • Country
  • ANIX United States
  • PFX United States
  • Employees
  • ANIX N/A
  • PFX N/A
  • Industry
  • ANIX Biotechnology: Pharmaceutical Preparations
  • PFX Finance: Consumer Services
  • Sector
  • ANIX Health Care
  • PFX Finance
  • Exchange
  • ANIX Nasdaq
  • PFX Nasdaq
  • Market Cap
  • ANIX 108.9M
  • PFX 96.0M
  • IPO Year
  • ANIX 1987
  • PFX N/A
  • Fundamental
  • Price
  • ANIX $3.15
  • PFX $49.42
  • Analyst Decision
  • ANIX Strong Buy
  • PFX
  • Analyst Count
  • ANIX 3
  • PFX 0
  • Target Price
  • ANIX $9.00
  • PFX N/A
  • AVG Volume (30 Days)
  • ANIX 156.0K
  • PFX 1.8K
  • Earning Date
  • ANIX 09-05-2025
  • PFX 08-05-2025
  • Dividend Yield
  • ANIX N/A
  • PFX 2.91%
  • EPS Growth
  • ANIX N/A
  • PFX N/A
  • EPS
  • ANIX N/A
  • PFX 5.09
  • Revenue
  • ANIX N/A
  • PFX $24,036,577.00
  • Revenue This Year
  • ANIX N/A
  • PFX $10.51
  • Revenue Next Year
  • ANIX N/A
  • PFX N/A
  • P/E Ratio
  • ANIX N/A
  • PFX $9.65
  • Revenue Growth
  • ANIX N/A
  • PFX 15.02
  • 52 Week Low
  • ANIX $2.07
  • PFX $44.56
  • 52 Week High
  • ANIX $4.20
  • PFX $57.40
  • Technical
  • Relative Strength Index (RSI)
  • ANIX 48.71
  • PFX 47.15
  • Support Level
  • ANIX $3.18
  • PFX $50.00
  • Resistance Level
  • ANIX $3.39
  • PFX $51.50
  • Average True Range (ATR)
  • ANIX 0.19
  • PFX 0.50
  • MACD
  • ANIX -0.05
  • PFX 0.04
  • Stochastic Oscillator
  • ANIX 4.41
  • PFX 32.97

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.

About PFX PhenixFIN Corporation

PhenixFIN Corp is a non-diversified closed end management investment company operating in United States. Its investment objective is to generate current income and capital appreciation by lending directly to privately held middle market companies to expand their business, refinance and make acquisitions. It mainly invests in senior secured first lien term loans, senior secured second lien term loans, unitranche, senior secured first lien notes, subordinated notes and warrants and minority equity securities. It may also invest in securities of foreign companies. Portfolio of the company mainly consists of securities across all sectors. Revenue generated by the company comprises of interest income, dividend and other income earned through investments made.

Share on Social Networks: